JD HEALTH

Forecast & Rating18 analysts currently cover JD HEALTH, with about 94.4% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$68.40, about 94.0% upside from the current price of HK$35.26. Price targets range from HK$49.79 to HK$95.72 — a wide spread, showing clear disagreement over just how much JD HEALTH can rise. Historically, about 43.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study JD HEALTH closely still see room for the stock to rise. Data as of Sep 8, 2026; for reference only and not investment advice.